Heron Historical Income Statement
| HRTX Stock | USD 1.07 0.01 0.94% |
Historical analysis of Heron Therapeuti income statement accounts such as Total Revenue of 133.4 M or Gross Profit of 65 M can show how well Heron Therapeuti performed in making a profits. Evaluating Heron Therapeuti income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Heron Therapeuti's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Heron Therapeuti latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Heron Therapeuti is a good buy for the upcoming year.
Heron |
About Heron Income Statement Analysis
Heron Therapeuti Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Heron Therapeuti shareholders. The income statement also shows Heron investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Heron Therapeuti Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Heron Therapeuti. It is also known as Heron Therapeuti overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Heron Therapeuti income statement and represents the costs associated with goods and services Heron Therapeuti provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Heron Therapeuti's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Heron Therapeuti current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heron Therapeuti. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.At this time, Heron Therapeuti's Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 4.1 M in 2024, despite the fact that Operating Income is likely to grow to (105.1 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 258.2M | 227.5M | 172.6M | 181.2M | Cost Of Revenue | 46.0M | 54.9M | 65.1M | 68.4M |
Heron Therapeuti income statement Correlations
Click cells to compare fundamentals
Heron Therapeuti Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Heron Therapeuti income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 2.0M | 2.8M | 3.0M | 2.9M | 2.9M | 3.0M | |
| Interest Expense | 1.5M | 1.9M | 2.4M | 2.5M | 3.9M | 4.1M | |
| Total Revenue | 146.0M | 88.6M | 86.3M | 107.7M | 127.0M | 133.4M | |
| Gross Profit | 84.3M | 52.4M | 40.3M | 52.8M | 61.9M | 65.0M | |
| Other Operating Expenses | 356.7M | 316.8M | 304.2M | 282.3M | 237.7M | 249.5M | |
| Operating Income | (210.7M) | (228.2M) | (217.8M) | (174.7M) | (110.6M) | (105.1M) | |
| Ebit | (210.7M) | (228.2M) | (217.8M) | (174.7M) | (106.7M) | (101.4M) | |
| Ebitda | (208.7M) | (225.3M) | (214.8M) | (171.8M) | (103.8M) | (98.6M) | |
| Cost Of Revenue | 61.6M | 36.2M | 46.0M | 54.9M | 65.1M | 68.4M | |
| Total Operating Expenses | 295.0M | 280.6M | 258.2M | 227.5M | 172.6M | 181.2M | |
| Income Before Tax | (204.7M) | (227.3M) | (220.7M) | (182.0M) | (110.6M) | (105.0M) | |
| Total Other Income Expense Net | 5.9M | 885K | (2.9M) | (7.4M) | 56K | 53.2K | |
| Net Income | (204.7M) | (224.4M) | (217.7M) | (134.5M) | (110.6M) | (105.0M) | |
| Income Tax Expense | 1.9M | (2.8M) | (3.0M) | (47.5M) | 2.7M | 2.9M | |
| Research Development | 167.4M | 174.5M | 130.8M | 107.5M | 55.9M | 48.9M | |
| Selling General Administrative | 37.9M | 42.2M | 40.2M | 37.4M | 49.0M | 51.5M | |
| Net Income Applicable To Common Shares | (204.7M) | (227.3M) | (220.7M) | (182.0M) | (163.8M) | (172.0M) | |
| Net Income From Continuing Ops | (204.7M) | (227.3M) | (220.7M) | (182.0M) | (119.7M) | (125.7M) | |
| Selling And Marketing Expenses | 89.8M | 63.9M | 87.2M | 82.5M | 67.6M | 64.4M | |
| Non Operating Income Net Other | 7.8M | 7.4M | 2.8M | (445K) | (511.8K) | (486.2K) | |
| Net Interest Income | 5.8M | 1.7M | (2.0M) | (836K) | (504K) | (478.8K) | |
| Interest Income | 7.3M | 3.6M | 433K | 1.6M | 3.4M | 2.6M | |
| Reconciled Depreciation | 2.0M | 2.8M | 3.0M | 2.9M | 3.0M | 2.6M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Heron Stock Analysis
When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.